Food and Drug Administration, HHS § 1308.33

TABLE OF EXEMPT PRESCRIPTION PRODUCTSÐContinued

(mg or Company Trade Name NDC Code Form Controlled Substance mg/ml)

Winthrop Labs ...... Isuprel ...... 00024±0874 EL Phenobarbital ...... 0.40 Zenith Labs Inc ...... Azpan ...... 00172±3747 TB Phenobarbital ...... 8.00

[52 FR 9803, Mar. 27, 1987, as amended at 53 (7) Information to facilitate identi- FR 10861, April 1, 1988; 54 FR 11520, Mar. 21, fication of the dosage form, such as 1989; 55 FR 9114, Mar. 12, 1990; 57 FR 23301, shape, color, coating, and scoring; June 3, 1992] (8) The label and labeling of the im- mediate container and the commercial EXEMPT ANABOLIC PRODUCTS containers, if any, of the product; § 1308.33 Exemption of certain ana- (9) The units in which the dosage bolic steroid products; application. form is ordinarily available; and (10) The facts which the applicant be- (a) The Administrator, upon the rec- lieves justify: ommendation of the Secretary of (i) A determination that the product Health and Human Services, may, by has no significant potential for abuse regulation, exempt from the applica- and tion of all or any part of the Act any (ii) a granting of an exemption under compound, mixture, or preparation this section. containing an as de- (d) Within a reasonable period of fined in § 1308.02 if, because of its con- time after the receipt of the applica- centration, preparation, mixture or de- tion for an exemption under this sec- livery system, it has no significant po- tion, the Administrator shall notify tential for abuse (Pub. L. 101–647 sec- the applicant of his acceptance or non- tion 1903(a)). acceptance of the application, and if (b) Any person seeking to have any not accepted, the reason therefor. The compound, mixture, or preparation Administrator need not accept an ap- containing an anabolic steroid as de- plication for filing if any of the re- fined in § 1308.02 exempted from the ap- quirements prescribed in paragraph (c) plication of all or any part of the Act, of this section is lacking or is not set pursuant to paragraph (a) of this sec- forth so as to be readily understood. tion, may apply to the Administrator, The applicant may amend the applica- Drug Enforcement Administration, De- tion to meet the requirements of para- partment of Justice, Washington, DC graph (c) of this section. If accepted for 20537. filing, the Administrator will request (c) An application for an exemption from the Secretary for Health and under this section shall be submitted Human Services his recommendation, in triplicate and contain the following as to whether such product which con- information: tains an anabolic steroid should be con- (1) The name and address of the ap- sidered for exemption from certain por- plicant; tions of the Controlled Substances Act. On receipt of the recommendation of (2) The name of the product; the Secretary, the Administrator shall (3) The chemical structural formula make a determination as to whether or description for any anabolic steroid the evidence submitted or otherwise contained in the product; available sufficiently establishes that (4) The complete description of dos- the product possesses no significant po- age and quantitative composition of tential for abuse. The Administrator the dosage form; shall issue and publish in the FEDERAL (5) A description of the delivery sys- REGISTER his order on the application, tem, if applicable; which shall include a reference to the (6) The indications and conditions for legal authority under which the order use in which species, including whether is issued, and the findings of fact and or not this product is a prescription conclusions of law upon which the drug; order is based. This order shall specify

181

VerDate 1496 10:36 Jul 12, 1996 Jkt 167073 PO 00000 Frm 00178 Fmt 8010 Sfmt 8010 C:\CFR\21V9C2.TXT pfrm13 § 1308.34 21 CFR Ch. II (4–1–96 Edition)

the date on which it will take effect. following the procedures set forth in The Administrator shall permit any in- paragraph (d) of this section for han- terested person to file written com- dling an application for an exemption ments on or objections to the order which has been accepted for filing. within 60 days of the date of publica- tion of his order in the FEDERAL REG- [56 FR 42936, Aug. 30, 1991; 57 FR 10815, Mar. 31, 1992] ISTER. If any such comments or objec- tions raise significant issues regarding § 1308.34 Exempt anabolic steroid any finding of fact or conclusion of law products. upon which the order is based, the Ad- ministrator shall immediately suspend The following anabolic steroid con- the effectiveness of the order until he taining compounds, mixtures, or may reconsider the application in light preparations have been exempted by of the comments and objections filed. the Administrator from application of Thereafter, the Administrator shall re- sections 302 through 309 and 1002 instate, revoke, or amend his original through 1004 of the Act (21 U.S.C. 822– order as he determines appropriate. 829 and 952–954) and §§ 1301.24, 1301.31, (e) The Administrator may revoke 1301.32, and 1301.71 through 1301.76 of any exemption granted pursuant to this chapter for administrative pur- section 1903(a) of Public Law 101–647 by poses only:

TABLE OF EXEMPT ANABOLIC STEROID PRODUCTS

Trade name Company NDC No. Form Ingredients Quantity

Androgyn L.A...... Forest Pharma- 0456±1005 ...... Vial ...... enanthate 90 mg/ml ceuticals, St. Louis, valerate ...... 4 mg/ml MO. Andro-Estro 90±4 ...... Rugby Laboratories, 0536±1605 ...... Vial ...... 90 mg/ml Rockville Centre, NY. ...... 4 mg/ml depANDROGYN ...... Forest Pharma- 0456±1020 ...... Vial ...... 50 mg/ml ceuticals, St. Louis, ...... 2 mg/ml MO. DEPO±T.E...... Quality Research 52765±257 ...... Vial ...... Testosterone cypionate 50 mg/ml Pharm., Carmel, IN. Estradiol cypionate ...... 2 mg/ml depTESTROGEN ...... Martica Pharma- 51698±257 ...... Vial ...... Testosterone cypionate 50 mg/ml ceuticals, Phoenix, Estradiol cypionate ...... 2 mg/ml AZ. Duomone ...... Wintec Pharmaceutical, 52047±360 ...... Vial ...... Testosterone enanthate 90 mg/ml Pacific, MO. Estradiol valerate ...... 4 mg/ml DURATESTRIN ...... W.E. Hauck, 43797±016 ...... Vial ...... Testosterone cypionate 50 mg/ml Alpharetta, GA. Estradiol cypionate ...... 2 mg/ml DUO±SPAN II ...... Primedics Laboratories, 0684±0102 ...... Vial ...... Testosterone cyplonate 50 mg/ml Gardena, CA. Esterified cypionate ..... 2 mg/ml Estratest ...... Solvay Pharma- 0032±1026 ...... TB ...... Esterified ..... 1.25 mg ceuticals, Marletta, ...... 2.5 mg GA. Estratest HS ...... Solvay Pharma- 0032±1023 ...... TB ...... ..... 0.625 mg ceuticals, Marletta, Methyltestosterone ...... 1.25 mg GA. PAN ESTRA TEST ...... Pan American Labs, 0525±0175 ...... Vial ...... Testosterone cypionate 50 mg/ml Covington, LA. Estradiol cypionate ...... 2 mg/ml Premarin with Ayerst Labs. Inc., New 0046±0879 ...... TB ...... 1.25 mg Methyltestosterone. York, NY. Methyltestosterone ...... 10.0 mg Premarin with Ayerst Labs. Inc., New 0046±0878 ...... TB ...... Conjugated estrogens 0.625 mg Methyltestosterone. York, NY. Methyltestosterone ...... 5.0 mg Synovex H Pellets in Syntex Animal Health, ...... Drum ...... Testosterone propio- 25 mg. process. Palo Alto, CA. nate. 2.5 mg. ...... Synovex H Pellets in Syntex Animal Health, ...... Drum ...... Testosterone propio- 10 parts. process granulation. Palo Alto, CA. nate. 1 part. Estradiol benzoate ...... TEST±ESTRO Rugby Laboratories, 0536±9470 ...... Vial ...... Testosterone cypionate 50 mg/ml Cypionates. Rockville Centre, NY. Estradiol cypionate ...... 2 mg/ml Testagen ...... Clint Pharmaceuticals, 55553±257 ...... Vial ...... Testosterone cypionate 50 mg/ml. Nashville, TN. Estradiol cypionate ...... 2 mg/ml. Testosterone Cyp 50 I.D.E.-Interstate, Amity- 0814±7737 ...... Vial ...... Testosterone cypionate 50 mg/ml Estradiol Cyp 2. ville, NY. Estradiol cypionate ...... 2 mg/ml

182

VerDate 1496 10:36 Jul 12, 1996 Jkt 167073 PO 00000 Frm 00179 Fmt 8010 Sfmt 8010 C:\CFR\21V9C2.TXT pfrm13